«Effectiveness and safety of the monoclonal antibody drug lecanemab (Leqembi) in reducing beta-amyloid plaques in alzheimer’s dementia: a literature review». Journal of Health Management and Pharmacy Exploration, libk. 3, zenb. 1, 2025(e)ko otsailaren, https://doi.org/10.52465/johmpe.v3i1.547.